(Press-News.org) Thousands of sequences that control genes are active in the developing human limb and may have driven the evolution of the human hand and foot, a comparative genomics study led by Yale School of Medicine researchers has found
The research, published online July 3 in the journal Cell, does not pinpoint the exact genetic mechanisms that control development of human limbs, but instead provides scientists with the first genome-wide view of candidates to investigate.
"We now have a parts list that may account for these biological changes," said James P. Noonan, associate professor of genetic, investigator for the Kavli Institute and senior author of the study.
Uniquely human features in the limbs can be seen early in human development, suggesting the genetic changes that underlie these traits are active in the human embryo. Previous studies compared the human genome to genomes of other primate species in order to identify changes in genetic sequences that may have occurred during human evolution. Noonan and colleagues used this approach in 2008 to identify a single human gene regulatory sequence showing human-specific activity in the developing limb that may have contributed to the evolution of the human thumb. However, it was unclear at the time how many of these elements exist within the human genome.
To address this, Noonan's group looked for differences in the activity of these regulatory sequences across the entire genomes of human, rhesus monkey, and mouse during limb development.
The team built maps of active gene regulatory sequences in developing limbs from each species using a biochemical marker known to identify such sequences. Their analysis suggests that while the genetics of limb development are generally similar in all three species, a fraction of regulatory sequences are active specifically in the human embryonic limb. These sequences likely gained activity since humans' divergence from the rhesus monkey about 25 million years ago.
Noonan said he plans to transfer some of these human-specific regulatory elements into the mouse genome to investigate what aspects of human limb development they may control.
"It has been difficult to understand how human traits evolved, because we didn't have any idea where the important genetic changes might be," Noonan said. "Now we do, and we have the experimental tools to determine what biological effects these changes may have. Our study also provides a roadmap for understanding other human-specific traits that arise during development, such as increased brain size and complexity."
###
The work was funded by the National Institutes of Health, the Edward J. Mallinckrodt Jr. Foundation, and the National Science Foundation.
The lead authors of the study are Justin Cotney and Jing Leng, both in the Noonan laboratory. Other Yale authors include Jun Yin, Steven K. Reilly, Laura E. DeMare, Deena Emera, Albert E. Ayoub, and Pasko Rakic
Evolution's toolkit seen in developing hands and arms
2013-07-03
ELSE PRESS RELEASES FROM THIS DATE:
New mechanism for human gene expression discovered
2013-07-03
In a study that could change the way scientists view the process of protein production in humans, University of Chicago researchers have found a single gene that encodes two separate proteins from the same sequence of messenger RNA.
Published online July 3 in Cell, their finding elucidates a previously unknown mechanism in human gene expression and opens the door for new therapeutic strategies against a thus-far untreatable neurological disease.
"This is the first example of a mechanism in a higher organism in which one gene creates two proteins from the same mRNA transcript, ...
Scientists identify gene that controls aggressiveness in breast cancer cells
2013-07-03
CAMBRIDGE, Mass. (July 3, 2013) – In a discovery that sheds new light on the aggressiveness of certain breast cancers, Whitehead Institute researchers have identified a transcription factor, known as ZEB1, that is capable of converting non-aggressive basal-type cancer cells into highly malignant, tumor-forming cancer stem cells (CSCs). Intriguingly, luminal breast cancer cells, which are associated with a much better clinical prognosis, carry this gene in a state in which it seems to be permanently shut down.
The researchers, whose findings are published this week ...
Altered protein shapes may explain differences in some brain diseases
2013-07-03
It only takes one bad apple to spoil the bunch, and the same may be true of certain proteins in the brain. Studies have suggested that just one rogue protein (in this case, a protein that is misfolded or shaped the wrong way) can act as a seed, leading to the misfolding of nearby proteins. According to an NIH-funded study, various forms of these seeds — originating from the same protein — may lead to different patterns of misfolding that result in neurological disorders with unique sets of symptoms.
"This study has important implications for Parkinson's disease and other ...
Tiny tweezers allow precision control of enzymes
2013-07-03
Tweezers are a handy instrument when it comes to removing a splinter or plucking an eyebrow.
In new research, Hao Yan and his colleagues at Arizona State University's Biodesign Institute describe a pair of tweezers shrunk down to an astonishingly tiny scale. When the jaws of these tools are in the open position, the distance between the two arms is about 16 nanometers—over 30,000 times smaller than a single grain of sand.
The group demonstrated that the nanotweezers, fabricated by means of the base-pairing properties of DNA, could be used to keep biological molecules ...
Study confirms adding chemotherapy to surgery improves survival in advanced gastric cancer
2013-07-03
Lugano-Barcelona, 3 July 2013 -- For patients with advanced gastric cancer, treatment with chemotherapy after surgery can reduce the risk of cancer related death by 34% over five years compared to surgery alone, researchers said at the 15th ESMO World Congress in Gastrointestinal Cancer.
At the meeting Prof Sung Hoon Noh, a gastric surgeon from Yonsei University College of Medicine, Korea, presented 5-year follow-up from the phase III CLASSIC trial, which added combination chemotherapy to a standard surgical procedure called D2 gastrectomy. The chemotherapy regimen studied ...
Study challenges long-held assumption of gene expression in embryonic stem cells
2013-07-03
CAMBRIDGE, Mass. (July 3, 2013) – Whitehead Institute researchers have determined that the transcription factor Nanog, which plays a critical role in the self-renewal of embryonic stem cells, is expressed in a manner similar to other pluripotency markers. This finding contradicts the field's presumptions about this important gene and its role in the differentiation of embryonic stem cells.
A large body of research has reported that Nanog is allelically regulated—that is, only one copy of the gene is expressed at any given time—and fluctuations in its expression are responsible ...
New papers identify a microRNA that drives both cancer onset and metastasis
2013-07-03
BOSTON -- A mere 25 years ago, noncoding RNAs were considered nothing more than "background noise" in the overall genomic landscape. Now, two new studies reveal that one of these tiny noncoding molecules – microRNA-22 – plays an outsized role in two types of cancer.
Reported on-line today in the journals Cell and Cell Stem Cell, the two papers demonstrate in mouse models that miR-22 drives both the onset and spread of breast cancer, as well as the onset of blood cancer. The findings, led by investigators at Beth Israel Deaconess Medical Center (BIDMC), further suggest ...
Hot flashes take heavier toll on women with HIV
2013-07-03
CLEVELAND, Ohio (July 3, 2013)—Women with HIV are living longer, so more are entering menopause. As they do, they suffer more severe hot flashes than women without HIV, and their hot flashes take a heavier toll on their quality of life and daily functioning, found researchers at Massachusetts General Hospital. Their study was published online today in Menopause, the journal of The North American Menopause Society.
That toll has the potential to undermine an already shaky foundation for their lives, compromising their health, HIV treatment, and ability to abstain from ...
Immune-boosting colorectal cancer drug shows promise
2013-07-03
Lugano-Barcelona-- New data on an emerging treatment that aims to fight colorectal cancer by stimulating the immune system have been presented at the ESMO 15th World Congress on Gastrointestinal Cancer.
The findings confirm the biological action of the drug called MGN1703 and suggest it may be possible to identify which gastrointestinal cancer patients will benefit most from the treatment, reported Prof Hans-Joachim Schmoll from Martin Luther University, Halle, Germany.
MGN1703 is a small DNA molecule recognised by a receptor --called toll-like receptor 9-- that is ...
Lifesaving HIV treatment could reach millions more people following landmark study
2013-07-03
Millions more people could get access to life-saving HIV drug therapy, following a landmark study led by Australian researchers based at the Kirby Institute at the University of New South Wales (UNSW).
The researchers have found a lower daily dose of an important HIV drug therapy is safe and as effective in suppressing the virus as the standard recommended dose.
The findings have been presented at the International AIDS Society Conference in Kuala Lumpur, Malaysia.
"This has the potential to affect the treatment of millions of HIV positive people," says UNSW Professor ...